M
Maria Effenberger
Researcher at Innsbruck Medical University
Publications - 57
Citations - 2046
Maria Effenberger is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 47 publications receiving 937 citations.
Papers
More filters
Journal ArticleDOI
Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis.
TL;DR: Asymptomatic patients may be contagious and thus a potential source of transmission of COVID-19, and more than half of the patients without any symptoms present with CT abnormalities.
Journal ArticleDOI
Immunopathogenesis and treatment of cytokine storm in COVID-19.
Jaeseok Kim,Jun Young Lee,Jae Won Yang,Keum Hwa Lee,Maria Effenberger,Wladimir Szpirt,Andreas Kronbichler,Jae Il Shin +7 more
TL;DR: The potential therapeutic role of extracorporeal cytokine removal to treat the cytokine storm associated with COVID-19 is discussed and expectations are especially high for new cytokine-targeted therapies, such as tocilizumab, anakinra, and baricitinib.
Journal ArticleDOI
Faecal calprotectin indicates intestinal inflammation in COVID-19.
Maria Effenberger,Felix Grabherr,Lisa Mayr,Julian Schwaerzler,Manfred Nairz,Markus Seifert,Richard Hilbe,Stefanie Seiwald,Sabine Scholl-Buergi,Gernot Fritsche,Rosa Bellmann-Weiler,Günter Weiss,Thomas Müller,Timon E. Adolph,Herbert Tilg +14 more
TL;DR: This pilot study explored a relation between GI symptoms, intestinal inflammation (determined by FC) and faecal SARS-CoV-2-RNA in hospitalised patients with COVID-19 who did not require intensive care measures.
Journal ArticleDOI
Association of the COVID-19 pandemic with internet search volumes: a google trendsTM analysis
TL;DR: Public interest indicated by RSV indices can help to monitor the progression of an outbreak such as the current COVID-19 pandemic and was very consistent across European countries but also holds true for the US.
Journal ArticleDOI
Auto-aggressive CXCR6 + CD8 T cells cause liver immune pathology in NASH
Michael Dudek,Dominik Pfister,Sainitin Donakonda,Pamela Filpe,Annika Schneider,Melanie Laschinger,Daniel Hartmann,Norbert Hüser,Philippa Meiser,Felix Bayerl,Donato Inverso,Donato Inverso,Jennifer Wigger,Marcial Sebode,Rupert Öllinger,Roland Rad,Silke Hegenbarth,Martina Anton,Adrien Guillot,Andrew P. Bowman,Danijela Heide,Florian Müller,Pierluigi Ramadori,Valentina Leone,Cristina García-Cáceres,Tim Gruber,Gabriel Seifert,Agnieszka M. Kabat,Jan-Philipp Mallm,Simon Reider,Maria Effenberger,Susanne Roth,Adrian T. Billeter,Beat P. Müller-Stich,Edward J. Pearce,Friedrich Koch-Nolte,Rafael Käser,Herbert Tilg,Robert Thimme,Tobias Boettler,Frank Tacke,Jean-François Dufour,Dirk Haller,Peter J. Murray,Peter J. Murray,Ron M. A. Heeren,Dietmar Zehn,Jan P. Böttcher,Mathias Heikenwalder,Percy A. Knolle +49 more
TL;DR: In this paper, a preclinical mouse model that displays key features of human NASH (hereafter, NASH mice), was used to detect the hepatic accumulation of CD8 T cells with phenotypes that combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics.